- Report
- February 2026
- 198 Pages
Global
From €4436EUR$4,950USD£3,806GBP
- Report
- April 2026
- 109 Pages
Global
From €3500EUR$4,184USD£3,108GBP
- Report
- April 2026
- 115 Pages
Global
From €3500EUR$4,184USD£3,108GBP
- Report
- April 2026
- 122 Pages
Global
From €3500EUR$4,184USD£3,108GBP
- Report
- April 2026
- 112 Pages
Global
From €3500EUR$4,184USD£3,108GBP
- Report
- December 2025
- 142 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- September 2025
- 140 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- March 2026
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 170 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 186 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- November 2025
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- October 2025
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- September 2025
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- September 2025
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- August 2025
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- October 2025
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- August 2025
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- August 2025
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- June 2026
- 53 Pages
Global
From €6722EUR$7,500USD£5,766GBP
- Report
- October 2025
- 87 Pages
Global
From €4033EUR$4,500USD£3,460GBP

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision.
Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more